nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—Melphalan—breast cancer	0.566	1	CrCrCtD
Baclofen—GABBR1—nipple—breast cancer	0.00539	0.148	CbGeAlD
Baclofen—GABBR2—adrenal gland—breast cancer	0.00521	0.143	CbGeAlD
Baclofen—GABBR2—endocrine gland—breast cancer	0.00452	0.124	CbGeAlD
Baclofen—GABBR1—endometrium—breast cancer	0.00325	0.0893	CbGeAlD
Baclofen—GABBR1—uterus—breast cancer	0.003	0.0823	CbGeAlD
Baclofen—GABBR1—pituitary gland—breast cancer	0.00294	0.0808	CbGeAlD
Baclofen—GABBR1—adipose tissue—breast cancer	0.00293	0.0804	CbGeAlD
Baclofen—GABBR1—adrenal gland—breast cancer	0.00263	0.0722	CbGeAlD
Baclofen—GABBR1—bone marrow—breast cancer	0.00254	0.0698	CbGeAlD
Baclofen—GABBR1—female gonad—breast cancer	0.00245	0.0673	CbGeAlD
Baclofen—GABBR1—lymph node—breast cancer	0.00158	0.0433	CbGeAlD
Baclofen—Chlorphenesin—CYP19A1—breast cancer	0.00081	0.14	CrCbGaD
Baclofen—Chlorphenesin—BCHE—breast cancer	0.000808	0.14	CrCbGaD
Baclofen—Ibuprofen—BCL2—breast cancer	0.000711	0.123	CrCbGaD
Baclofen—Ibuprofen—ABCC1—breast cancer	0.000644	0.112	CrCbGaD
Baclofen—Ibuprofen—CXCL8—breast cancer	0.00057	0.0987	CrCbGaD
Baclofen—Chlorpropamide—PTGS1—breast cancer	0.000494	0.0855	CrCbGaD
Baclofen—Chlorphenesin—CYP3A4—breast cancer	0.00038	0.0659	CrCbGaD
Baclofen—Chlorphenesin—PTGS2—breast cancer	0.000372	0.0645	CrCbGaD
Baclofen—Ibuprofen—PTGS1—breast cancer	0.000291	0.0503	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—breast cancer	0.00024	0.0415	CrCbGaD
Baclofen—Ibuprofen—PTGS2—breast cancer	0.000166	0.0288	CrCbGaD
Baclofen—Ibuprofen—ALB—breast cancer	0.000148	0.0256	CrCbGaD
Baclofen—Ibuprofen—ABCB1—breast cancer	0.000141	0.0245	CrCbGaD
Baclofen—GABBR1—Signaling Pathways—LPAR1—breast cancer	7.65e-05	0.000788	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—breast cancer	7.6e-05	0.000784	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HEY1—breast cancer	7.57e-05	0.00078	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG2—breast cancer	7.54e-05	0.000777	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HSP90AA1—breast cancer	7.42e-05	0.000765	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DLL1—breast cancer	7.42e-05	0.000765	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH2—breast cancer	7.42e-05	0.000765	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—breast cancer	7.36e-05	0.000759	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIST1H2BK—breast cancer	7.28e-05	0.000751	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIST1H2BC—breast cancer	7.28e-05	0.000751	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRB7—breast cancer	7.22e-05	0.000744	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRL—breast cancer	7.22e-05	0.000744	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AGTR1—breast cancer	7.22e-05	0.000744	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDE4D—breast cancer	7.22e-05	0.000744	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CSF2—breast cancer	7.19e-05	0.00074	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STK11—breast cancer	7.12e-05	0.000733	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ADAM10—breast cancer	7.12e-05	0.000733	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TAB2—breast cancer	7.1e-05	0.000731	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ITPR1—breast cancer	7.07e-05	0.000728	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR2—breast cancer	7.04e-05	0.000725	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLG—breast cancer	7.04e-05	0.000725	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—breast cancer	7.03e-05	0.000724	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MMP3—breast cancer	7.02e-05	0.000723	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT2—breast cancer	6.96e-05	0.000717	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF10—breast cancer	6.92e-05	0.000713	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DKK1—breast cancer	6.87e-05	0.000708	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFC—breast cancer	6.81e-05	0.000702	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TFRC—breast cancer	6.72e-05	0.000693	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAG2—breast cancer	6.71e-05	0.000692	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—breast cancer	6.69e-05	0.000689	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFA—breast cancer	6.68e-05	0.000688	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—WNT1—breast cancer	6.62e-05	0.000682	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PLA2G4A—breast cancer	6.6e-05	0.00068	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFBR2—breast cancer	6.58e-05	0.000678	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CSF2—breast cancer	6.53e-05	0.000672	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ITPR1—breast cancer	6.48e-05	0.000668	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NCOA2—breast cancer	6.47e-05	0.000667	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT5A—breast cancer	6.44e-05	0.000663	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP3—breast cancer	6.44e-05	0.000663	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB4—breast cancer	6.44e-05	0.000663	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—breast cancer	6.42e-05	0.000661	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH4—breast cancer	6.27e-05	0.000646	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SMAD4—breast cancer	6.23e-05	0.000642	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GZMB—breast cancer	6.23e-05	0.000642	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IGF1R—breast cancer	6.19e-05	0.000638	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC5A5—breast cancer	6.17e-05	0.000636	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—breast cancer	6.17e-05	0.000635	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HES1—breast cancer	6.09e-05	0.000627	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NCOR1—breast cancer	6.05e-05	0.000623	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PLA2G4A—breast cancer	6.05e-05	0.000623	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL2—breast cancer	6.05e-05	0.000623	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGTR2—breast cancer	6.05e-05	0.000623	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTHLH—breast cancer	5.98e-05	0.000616	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF1—breast cancer	5.98e-05	0.000616	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CSF2—breast cancer	5.98e-05	0.000616	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BMP2—breast cancer	5.98e-05	0.000616	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—RAF1—breast cancer	5.97e-05	0.000615	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—SLC2A1—breast cancer	5.96e-05	0.000614	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HRAS—breast cancer	5.94e-05	0.000612	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRG1—breast cancer	5.94e-05	0.000612	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—H2AFX—breast cancer	5.9e-05	0.000607	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—breast cancer	5.89e-05	0.000607	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—E2F1—breast cancer	5.85e-05	0.000603	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—breast cancer	5.83e-05	0.0006	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—breast cancer	5.8e-05	0.000597	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDNRB—breast cancer	5.79e-05	0.000597	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PGR—breast cancer	5.74e-05	0.000591	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—THBS1—breast cancer	5.71e-05	0.000588	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SPP1—breast cancer	5.62e-05	0.00058	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—breast cancer	5.6e-05	0.000577	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB3—breast cancer	5.56e-05	0.000573	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGFR2—breast cancer	5.55e-05	0.000572	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NCOA1—breast cancer	5.45e-05	0.000562	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FLT1—breast cancer	5.45e-05	0.000561	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF3—breast cancer	5.42e-05	0.000559	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SQSTM1—breast cancer	5.42e-05	0.000559	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—breast cancer	5.4e-05	0.000556	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAG1—breast cancer	5.35e-05	0.000552	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—breast cancer	5.35e-05	0.000551	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—breast cancer	5.33e-05	0.000549	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH3—breast cancer	5.33e-05	0.000549	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PARP1—breast cancer	5.33e-05	0.000549	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—PLG—breast cancer	5.32e-05	0.000548	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CALCA—breast cancer	5.27e-05	0.000543	CbGpPWpGaD
Baclofen—Bradycardia—Doxorubicin—breast cancer	5.22e-05	0.000177	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RPS6—breast cancer	5.2e-05	0.000536	CbGpPWpGaD
Baclofen—Dyspnoea—Docetaxel—breast cancer	5.2e-05	0.000177	CcSEcCtD
Baclofen—Somnolence—Docetaxel—breast cancer	5.18e-05	0.000176	CcSEcCtD
Baclofen—Mental disorder—Methotrexate—breast cancer	5.18e-05	0.000176	CcSEcCtD
Baclofen—Rash—Gemcitabine—breast cancer	5.18e-05	0.000176	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FGFR1—breast cancer	5.18e-05	0.000533	CbGpPWpGaD
Baclofen—Dermatitis—Gemcitabine—breast cancer	5.18e-05	0.000176	CcSEcCtD
Baclofen—Eye disorder—Epirubicin—breast cancer	5.17e-05	0.000176	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF4—breast cancer	5.16e-05	0.000532	CbGpPWpGaD
Baclofen—Tinnitus—Epirubicin—breast cancer	5.16e-05	0.000175	CcSEcCtD
Baclofen—Malnutrition—Methotrexate—breast cancer	5.15e-05	0.000175	CcSEcCtD
Baclofen—Headache—Gemcitabine—breast cancer	5.15e-05	0.000175	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Capecitabine—breast cancer	5.14e-05	0.000175	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CXCR4—breast cancer	5.14e-05	0.00053	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL12—breast cancer	5.14e-05	0.00053	CbGpPWpGaD
Baclofen—Cardiac disorder—Epirubicin—breast cancer	5.14e-05	0.000175	CcSEcCtD
Baclofen—Flushing—Epirubicin—breast cancer	5.14e-05	0.000175	CcSEcCtD
Baclofen—Vomiting—Fluorouracil—breast cancer	5.14e-05	0.000175	CcSEcCtD
Baclofen—Rhinitis—Doxorubicin—breast cancer	5.14e-05	0.000174	CcSEcCtD
Baclofen—Dyspepsia—Docetaxel—breast cancer	5.13e-05	0.000174	CcSEcCtD
Baclofen—Insomnia—Capecitabine—breast cancer	5.11e-05	0.000174	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HIF1A—breast cancer	5.1e-05	0.000525	CbGpPWpGaD
Baclofen—Hypoaesthesia—Doxorubicin—breast cancer	5.1e-05	0.000173	CcSEcCtD
Baclofen—Rash—Fluorouracil—breast cancer	5.09e-05	0.000173	CcSEcCtD
Baclofen—Dermatitis—Fluorouracil—breast cancer	5.09e-05	0.000173	CcSEcCtD
Baclofen—Paraesthesia—Capecitabine—breast cancer	5.07e-05	0.000172	CcSEcCtD
Baclofen—Decreased appetite—Docetaxel—breast cancer	5.07e-05	0.000172	CcSEcCtD
Baclofen—Headache—Fluorouracil—breast cancer	5.06e-05	0.000172	CcSEcCtD
Baclofen—Urinary tract disorder—Doxorubicin—breast cancer	5.06e-05	0.000172	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PAK1—breast cancer	5.05e-05	0.00052	CbGpPWpGaD
Baclofen—Oedema peripheral—Doxorubicin—breast cancer	5.05e-05	0.000171	CcSEcCtD
Baclofen—Dysgeusia—Methotrexate—breast cancer	5.04e-05	0.000171	CcSEcCtD
Baclofen—Gastrointestinal disorder—Docetaxel—breast cancer	5.04e-05	0.000171	CcSEcCtD
Baclofen—Connective tissue disorder—Doxorubicin—breast cancer	5.03e-05	0.000171	CcSEcCtD
Baclofen—Dyspnoea—Capecitabine—breast cancer	5.03e-05	0.000171	CcSEcCtD
Baclofen—Fatigue—Docetaxel—breast cancer	5.03e-05	0.000171	CcSEcCtD
Baclofen—Angiopathy—Epirubicin—breast cancer	5.02e-05	0.000171	CcSEcCtD
Baclofen—Urethral disorder—Doxorubicin—breast cancer	5.02e-05	0.000171	CcSEcCtD
Baclofen—Nausea—Mitoxantrone—breast cancer	5.01e-05	0.00017	CcSEcCtD
Baclofen—Nausea—Irinotecan—breast cancer	5.01e-05	0.00017	CcSEcCtD
Baclofen—Mediastinal disorder—Epirubicin—breast cancer	4.99e-05	0.00017	CcSEcCtD
Baclofen—Constipation—Docetaxel—breast cancer	4.99e-05	0.000169	CcSEcCtD
Baclofen—Pain—Docetaxel—breast cancer	4.99e-05	0.000169	CcSEcCtD
Baclofen—Back pain—Methotrexate—breast cancer	4.98e-05	0.000169	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—LEP—breast cancer	4.98e-05	0.000513	CbGpPWpGaD
Baclofen—Dyspepsia—Capecitabine—breast cancer	4.97e-05	0.000169	CcSEcCtD
Baclofen—Chills—Epirubicin—breast cancer	4.97e-05	0.000169	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TCF7L2—breast cancer	4.96e-05	0.000511	CbGpPWpGaD
Baclofen—Arrhythmia—Epirubicin—breast cancer	4.95e-05	0.000168	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AKT2—breast cancer	4.94e-05	0.000509	CbGpPWpGaD
Baclofen—Visual impairment—Doxorubicin—breast cancer	4.94e-05	0.000168	CcSEcCtD
Baclofen—Asthenia—Paclitaxel—breast cancer	4.94e-05	0.000168	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CAV1—breast cancer	4.93e-05	0.000508	CbGpPWpGaD
Baclofen—Decreased appetite—Capecitabine—breast cancer	4.91e-05	0.000167	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—breast cancer	4.91e-05	0.000505	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—breast cancer	4.9e-05	0.000505	CbGpPWpGaD
Baclofen—Alopecia—Epirubicin—breast cancer	4.89e-05	0.000166	CcSEcCtD
Baclofen—Nausea—Gemcitabine—breast cancer	4.88e-05	0.000166	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—KDR—breast cancer	4.88e-05	0.000502	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Capecitabine—breast cancer	4.87e-05	0.000166	CcSEcCtD
Baclofen—Fatigue—Capecitabine—breast cancer	4.87e-05	0.000165	CcSEcCtD
Baclofen—Pruritus—Paclitaxel—breast cancer	4.87e-05	0.000165	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—breast cancer	4.85e-05	0.000165	CcSEcCtD
Baclofen—Mental disorder—Epirubicin—breast cancer	4.85e-05	0.000165	CcSEcCtD
Baclofen—Pain—Capecitabine—breast cancer	4.83e-05	0.000164	CcSEcCtD
Baclofen—Constipation—Capecitabine—breast cancer	4.83e-05	0.000164	CcSEcCtD
Baclofen—Malnutrition—Epirubicin—breast cancer	4.82e-05	0.000164	CcSEcCtD
Baclofen—Feeling abnormal—Docetaxel—breast cancer	4.81e-05	0.000163	CcSEcCtD
Baclofen—Nausea—Fluorouracil—breast cancer	4.8e-05	0.000163	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—breast cancer	4.79e-05	0.000163	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HSP90AA1—breast cancer	4.78e-05	0.000493	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOTCH2—breast cancer	4.78e-05	0.000493	CbGpPWpGaD
Baclofen—Ill-defined disorder—Methotrexate—breast cancer	4.78e-05	0.000162	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—breast cancer	4.78e-05	0.000162	CcSEcCtD
Baclofen—Gastrointestinal pain—Docetaxel—breast cancer	4.77e-05	0.000162	CcSEcCtD
Baclofen—Anaemia—Methotrexate—breast cancer	4.76e-05	0.000162	CcSEcCtD
Baclofen—Flushing—Doxorubicin—breast cancer	4.75e-05	0.000162	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—breast cancer	4.75e-05	0.000162	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ESR1—breast cancer	4.75e-05	0.00049	CbGpPWpGaD
Baclofen—Flatulence—Epirubicin—breast cancer	4.75e-05	0.000161	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—breast cancer	4.74e-05	0.000489	CbGpPWpGaD
Baclofen—Dysgeusia—Epirubicin—breast cancer	4.72e-05	0.00016	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—breast cancer	4.71e-05	0.000485	CbGpPWpGaD
Baclofen—Diarrhoea—Paclitaxel—breast cancer	4.71e-05	0.00016	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—FN1—breast cancer	4.69e-05	0.000484	CbGpPWpGaD
Baclofen—Back pain—Epirubicin—breast cancer	4.66e-05	0.000158	CcSEcCtD
Baclofen—Feeling abnormal—Capecitabine—breast cancer	4.65e-05	0.000158	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—AGTR1—breast cancer	4.65e-05	0.000479	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRL—breast cancer	4.65e-05	0.000479	CbGpPWpGaD
Baclofen—Angiopathy—Doxorubicin—breast cancer	4.65e-05	0.000158	CcSEcCtD
Baclofen—Malaise—Methotrexate—breast cancer	4.64e-05	0.000158	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NFKBIA—breast cancer	4.64e-05	0.000478	CbGpPWpGaD
Baclofen—Vertigo—Methotrexate—breast cancer	4.63e-05	0.000157	CcSEcCtD
Baclofen—Gastrointestinal pain—Capecitabine—breast cancer	4.62e-05	0.000157	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—breast cancer	4.62e-05	0.000157	CcSEcCtD
Baclofen—Body temperature increased—Docetaxel—breast cancer	4.61e-05	0.000157	CcSEcCtD
Baclofen—Abdominal pain—Docetaxel—breast cancer	4.61e-05	0.000157	CcSEcCtD
Baclofen—Chills—Doxorubicin—breast cancer	4.6e-05	0.000156	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NOTCH1—breast cancer	4.59e-05	0.000473	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADAM10—breast cancer	4.59e-05	0.000472	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STK11—breast cancer	4.59e-05	0.000472	CbGpPWpGaD
Baclofen—Arrhythmia—Doxorubicin—breast cancer	4.58e-05	0.000155	CcSEcCtD
Baclofen—Dizziness—Paclitaxel—breast cancer	4.55e-05	0.000155	CcSEcCtD
Baclofen—Vision blurred—Epirubicin—breast cancer	4.54e-05	0.000154	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PLG—breast cancer	4.53e-05	0.000467	CbGpPWpGaD
Baclofen—Alopecia—Doxorubicin—breast cancer	4.53e-05	0.000154	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—breast cancer	4.49e-05	0.000463	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KIT—breast cancer	4.49e-05	0.000463	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—APC—breast cancer	4.49e-05	0.000463	CbGpPWpGaD
Baclofen—Mental disorder—Doxorubicin—breast cancer	4.49e-05	0.000152	CcSEcCtD
Baclofen—Urticaria—Capecitabine—breast cancer	4.49e-05	0.000152	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AKT2—breast cancer	4.48e-05	0.000462	CbGpPWpGaD
Baclofen—Ill-defined disorder—Epirubicin—breast cancer	4.47e-05	0.000152	CcSEcCtD
Baclofen—Body temperature increased—Capecitabine—breast cancer	4.46e-05	0.000152	CcSEcCtD
Baclofen—Abdominal pain—Capecitabine—breast cancer	4.46e-05	0.000152	CcSEcCtD
Baclofen—Convulsion—Methotrexate—breast cancer	4.46e-05	0.000152	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF10—breast cancer	4.46e-05	0.00046	CbGpPWpGaD
Baclofen—Malnutrition—Doxorubicin—breast cancer	4.46e-05	0.000152	CcSEcCtD
Baclofen—Anaemia—Epirubicin—breast cancer	4.45e-05	0.000151	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EGF—breast cancer	4.44e-05	0.000458	CbGpPWpGaD
Baclofen—Agitation—Epirubicin—breast cancer	4.43e-05	0.00015	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—breast cancer	4.39e-05	0.000149	CcSEcCtD
Baclofen—Myalgia—Methotrexate—breast cancer	4.38e-05	0.000149	CcSEcCtD
Baclofen—Chest pain—Methotrexate—breast cancer	4.38e-05	0.000149	CcSEcCtD
Baclofen—Vomiting—Paclitaxel—breast cancer	4.37e-05	0.000149	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—breast cancer	4.37e-05	0.000148	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.35e-05	0.000148	CcSEcCtD
Baclofen—Malaise—Epirubicin—breast cancer	4.35e-05	0.000148	CcSEcCtD
Baclofen—Rash—Paclitaxel—breast cancer	4.34e-05	0.000147	CcSEcCtD
Baclofen—Dermatitis—Paclitaxel—breast cancer	4.33e-05	0.000147	CcSEcCtD
Baclofen—Discomfort—Methotrexate—breast cancer	4.33e-05	0.000147	CcSEcCtD
Baclofen—Vertigo—Epirubicin—breast cancer	4.33e-05	0.000147	CcSEcCtD
Baclofen—Syncope—Epirubicin—breast cancer	4.32e-05	0.000147	CcSEcCtD
Baclofen—Back pain—Doxorubicin—breast cancer	4.31e-05	0.000147	CcSEcCtD
Baclofen—Headache—Paclitaxel—breast cancer	4.31e-05	0.000146	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—breast cancer	4.31e-05	0.000444	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFA—breast cancer	4.3e-05	0.000443	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—breast cancer	4.3e-05	0.000443	CbGpPWpGaD
Baclofen—Palpitations—Epirubicin—breast cancer	4.26e-05	0.000145	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TGFBR2—breast cancer	4.24e-05	0.000437	CbGpPWpGaD
Baclofen—Confusional state—Methotrexate—breast cancer	4.24e-05	0.000144	CcSEcCtD
Baclofen—Loss of consciousness—Epirubicin—breast cancer	4.24e-05	0.000144	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—BRAF—breast cancer	4.22e-05	0.000435	CbGpPWpGaD
Baclofen—Vision blurred—Doxorubicin—breast cancer	4.2e-05	0.000143	CcSEcCtD
Baclofen—Asthenia—Docetaxel—breast cancer	4.18e-05	0.000142	CcSEcCtD
Baclofen—Convulsion—Epirubicin—breast cancer	4.18e-05	0.000142	CcSEcCtD
Baclofen—Infection—Methotrexate—breast cancer	4.18e-05	0.000142	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ITPR1—breast cancer	4.17e-05	0.00043	CbGpPWpGaD
Baclofen—Hypertension—Epirubicin—breast cancer	4.16e-05	0.000141	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—STAT5A—breast cancer	4.15e-05	0.000427	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP3—breast cancer	4.15e-05	0.000427	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB4—breast cancer	4.15e-05	0.000427	CbGpPWpGaD
Baclofen—Ill-defined disorder—Doxorubicin—breast cancer	4.14e-05	0.000141	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—breast cancer	4.14e-05	0.000426	CbGpPWpGaD
Baclofen—Pruritus—Docetaxel—breast cancer	4.13e-05	0.00014	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—breast cancer	4.12e-05	0.00014	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—breast cancer	4.12e-05	0.00014	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IGF1—breast cancer	4.11e-05	0.000424	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT2—breast cancer	4.11e-05	0.000424	CbGpPWpGaD
Baclofen—Chest pain—Epirubicin—breast cancer	4.1e-05	0.000139	CcSEcCtD
Baclofen—Myalgia—Epirubicin—breast cancer	4.1e-05	0.000139	CcSEcCtD
Baclofen—Agitation—Doxorubicin—breast cancer	4.1e-05	0.000139	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—EGFR—breast cancer	4.09e-05	0.000422	CbGpPWpGaD
Baclofen—Anxiety—Epirubicin—breast cancer	4.09e-05	0.000139	CcSEcCtD
Baclofen—Nausea—Paclitaxel—breast cancer	4.09e-05	0.000139	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—breast cancer	4.08e-05	0.000139	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.08e-05	0.000138	CcSEcCtD
Baclofen—Hyperhidrosis—Methotrexate—breast cancer	4.06e-05	0.000138	CcSEcCtD
Baclofen—Discomfort—Epirubicin—breast cancer	4.05e-05	0.000138	CcSEcCtD
Baclofen—Asthenia—Capecitabine—breast cancer	4.05e-05	0.000138	CcSEcCtD
Baclofen—Malaise—Doxorubicin—breast cancer	4.02e-05	0.000137	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SMAD4—breast cancer	4.02e-05	0.000414	CbGpPWpGaD
Baclofen—Dry mouth—Epirubicin—breast cancer	4.01e-05	0.000136	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—breast cancer	4.01e-05	0.000136	CcSEcCtD
Baclofen—Anorexia—Methotrexate—breast cancer	4.01e-05	0.000136	CcSEcCtD
Baclofen—Syncope—Doxorubicin—breast cancer	4e-05	0.000136	CcSEcCtD
Baclofen—Pruritus—Capecitabine—breast cancer	3.99e-05	0.000136	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IGF1R—breast cancer	3.99e-05	0.000411	CbGpPWpGaD
Baclofen—Diarrhoea—Docetaxel—breast cancer	3.99e-05	0.000136	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—breast cancer	3.97e-05	0.000409	CbGpPWpGaD
Baclofen—Confusional state—Epirubicin—breast cancer	3.97e-05	0.000135	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—breast cancer	3.95e-05	0.000407	CbGpPWpGaD
Baclofen—Palpitations—Doxorubicin—breast cancer	3.94e-05	0.000134	CcSEcCtD
Baclofen—Oedema—Epirubicin—breast cancer	3.93e-05	0.000134	CcSEcCtD
Baclofen—Hypotension—Methotrexate—breast cancer	3.93e-05	0.000133	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—HES1—breast cancer	3.92e-05	0.000404	CbGpPWpGaD
Baclofen—Loss of consciousness—Doxorubicin—breast cancer	3.92e-05	0.000133	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—breast cancer	3.91e-05	0.000403	CbGpPWpGaD
Baclofen—Infection—Epirubicin—breast cancer	3.91e-05	0.000133	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—breast cancer	3.91e-05	0.000402	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NCOR1—breast cancer	3.9e-05	0.000402	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PLA2G4A—breast cancer	3.9e-05	0.000402	CbGpPWpGaD
Baclofen—Shock—Epirubicin—breast cancer	3.87e-05	0.000131	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—KRAS—breast cancer	3.87e-05	0.000398	CbGpPWpGaD
Baclofen—Convulsion—Doxorubicin—breast cancer	3.86e-05	0.000131	CcSEcCtD
Baclofen—Diarrhoea—Capecitabine—breast cancer	3.86e-05	0.000131	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—breast cancer	3.86e-05	0.000131	CcSEcCtD
Baclofen—Dizziness—Docetaxel—breast cancer	3.86e-05	0.000131	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF1—breast cancer	3.86e-05	0.000397	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CSF2—breast cancer	3.86e-05	0.000397	CbGpPWpGaD
Baclofen—Hypertension—Doxorubicin—breast cancer	3.85e-05	0.000131	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—RAF1—breast cancer	3.85e-05	0.000396	CbGpPWpGaD
Baclofen—Tachycardia—Epirubicin—breast cancer	3.84e-05	0.00013	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—breast cancer	3.83e-05	0.00013	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NRG1—breast cancer	3.83e-05	0.000394	CbGpPWpGaD
Baclofen—Skin disorder—Epirubicin—breast cancer	3.82e-05	0.00013	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—breast cancer	3.8e-05	0.000129	CcSEcCtD
Baclofen—Insomnia—Methotrexate—breast cancer	3.8e-05	0.000129	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—H2AFX—breast cancer	3.8e-05	0.000391	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—breast cancer	3.8e-05	0.000391	CbGpPWpGaD
Baclofen—Chest pain—Doxorubicin—breast cancer	3.8e-05	0.000129	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—breast cancer	3.8e-05	0.000129	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—breast cancer	3.78e-05	0.000129	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—breast cancer	3.77e-05	0.000128	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—E2F1—breast cancer	3.77e-05	0.000389	CbGpPWpGaD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.77e-05	0.000128	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—breast cancer	3.76e-05	0.000387	CbGpPWpGaD
Baclofen—Discomfort—Doxorubicin—breast cancer	3.75e-05	0.000127	CcSEcCtD
Baclofen—Anorexia—Epirubicin—breast cancer	3.75e-05	0.000127	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—breast cancer	3.75e-05	0.000127	CcSEcCtD
Baclofen—Somnolence—Methotrexate—breast cancer	3.74e-05	0.000127	CcSEcCtD
Baclofen—Dizziness—Capecitabine—breast cancer	3.73e-05	0.000127	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—NOS3—breast cancer	3.73e-05	0.000384	CbGpPWpGaD
Baclofen—Dry mouth—Doxorubicin—breast cancer	3.71e-05	0.000126	CcSEcCtD
Baclofen—Vomiting—Docetaxel—breast cancer	3.71e-05	0.000126	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—breast cancer	3.7e-05	0.000126	CcSEcCtD
Baclofen—Rash—Docetaxel—breast cancer	3.68e-05	0.000125	CcSEcCtD
Baclofen—Hypotension—Epirubicin—breast cancer	3.68e-05	0.000125	CcSEcCtD
Baclofen—Dermatitis—Docetaxel—breast cancer	3.67e-05	0.000125	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—breast cancer	3.67e-05	0.000125	CcSEcCtD
Baclofen—Decreased appetite—Methotrexate—breast cancer	3.65e-05	0.000124	CcSEcCtD
Baclofen—Headache—Docetaxel—breast cancer	3.65e-05	0.000124	CcSEcCtD
Baclofen—Oedema—Doxorubicin—breast cancer	3.64e-05	0.000124	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—breast cancer	3.63e-05	0.000123	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SPP1—breast cancer	3.62e-05	0.000373	CbGpPWpGaD
Baclofen—Fatigue—Methotrexate—breast cancer	3.62e-05	0.000123	CcSEcCtD
Baclofen—Infection—Doxorubicin—breast cancer	3.62e-05	0.000123	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—breast cancer	3.61e-05	0.000372	CbGpPWpGaD
Baclofen—Pain—Methotrexate—breast cancer	3.59e-05	0.000122	CcSEcCtD
Baclofen—Vomiting—Capecitabine—breast cancer	3.59e-05	0.000122	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ERBB3—breast cancer	3.59e-05	0.000369	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Epirubicin—breast cancer	3.58e-05	0.000122	CcSEcCtD
Baclofen—Shock—Doxorubicin—breast cancer	3.58e-05	0.000122	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGFR2—breast cancer	3.58e-05	0.000369	CbGpPWpGaD
Baclofen—Nervous system disorder—Doxorubicin—breast cancer	3.57e-05	0.000121	CcSEcCtD
Baclofen—Rash—Capecitabine—breast cancer	3.56e-05	0.000121	CcSEcCtD
Baclofen—Insomnia—Epirubicin—breast cancer	3.56e-05	0.000121	CcSEcCtD
Baclofen—Dermatitis—Capecitabine—breast cancer	3.56e-05	0.000121	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—breast cancer	3.55e-05	0.000121	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—breast cancer	3.55e-05	0.000366	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDM2—breast cancer	3.54e-05	0.000365	CbGpPWpGaD
Baclofen—Headache—Capecitabine—breast cancer	3.54e-05	0.00012	CcSEcCtD
Baclofen—Skin disorder—Doxorubicin—breast cancer	3.54e-05	0.00012	CcSEcCtD
Baclofen—Paraesthesia—Epirubicin—breast cancer	3.53e-05	0.00012	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RAF1—breast cancer	3.53e-05	0.000363	CbGpPWpGaD
Baclofen—Hyperhidrosis—Doxorubicin—breast cancer	3.52e-05	0.00012	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RELA—breast cancer	3.51e-05	0.000362	CbGpPWpGaD
Baclofen—Dyspnoea—Epirubicin—breast cancer	3.51e-05	0.000119	CcSEcCtD
Baclofen—Somnolence—Epirubicin—breast cancer	3.5e-05	0.000119	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ERBB2—breast cancer	3.49e-05	0.000359	CbGpPWpGaD
Baclofen—Anorexia—Doxorubicin—breast cancer	3.47e-05	0.000118	CcSEcCtD
Baclofen—Nausea—Docetaxel—breast cancer	3.46e-05	0.000118	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—breast cancer	3.46e-05	0.000118	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—breast cancer	3.46e-05	0.000118	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—IL2—breast cancer	3.45e-05	0.000355	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—breast cancer	3.44e-05	0.000355	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—breast cancer	3.44e-05	0.000355	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Methotrexate—breast cancer	3.44e-05	0.000117	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TERT—breast cancer	3.44e-05	0.000354	CbGpPWpGaD
Baclofen—Decreased appetite—Epirubicin—breast cancer	3.42e-05	0.000116	CcSEcCtD
Baclofen—Hypotension—Doxorubicin—breast cancer	3.4e-05	0.000116	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—breast cancer	3.4e-05	0.000115	CcSEcCtD
Baclofen—Fatigue—Epirubicin—breast cancer	3.39e-05	0.000115	CcSEcCtD
Baclofen—Constipation—Epirubicin—breast cancer	3.36e-05	0.000114	CcSEcCtD
Baclofen—Pain—Epirubicin—breast cancer	3.36e-05	0.000114	CcSEcCtD
Baclofen—Nausea—Capecitabine—breast cancer	3.35e-05	0.000114	CcSEcCtD
Baclofen—Urticaria—Methotrexate—breast cancer	3.34e-05	0.000113	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGFR1—breast cancer	3.34e-05	0.000344	CbGpPWpGaD
Baclofen—Body temperature increased—Methotrexate—breast cancer	3.32e-05	0.000113	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—breast cancer	3.32e-05	0.000113	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.32e-05	0.000113	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCL8—breast cancer	3.31e-05	0.000341	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—breast cancer	3.29e-05	0.000112	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—HRAS—breast cancer	3.29e-05	0.000339	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HIF1A—breast cancer	3.29e-05	0.000339	CbGpPWpGaD
Baclofen—Paraesthesia—Doxorubicin—breast cancer	3.27e-05	0.000111	CcSEcCtD
Baclofen—Dyspnoea—Doxorubicin—breast cancer	3.25e-05	0.00011	CcSEcCtD
Baclofen—Feeling abnormal—Epirubicin—breast cancer	3.24e-05	0.00011	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—breast cancer	3.24e-05	0.00011	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—breast cancer	3.23e-05	0.000333	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Epirubicin—breast cancer	3.22e-05	0.000109	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—LEP—breast cancer	3.21e-05	0.000331	CbGpPWpGaD
Baclofen—Dyspepsia—Doxorubicin—breast cancer	3.2e-05	0.000109	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—breast cancer	3.2e-05	0.000329	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CAV1—breast cancer	3.18e-05	0.000327	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—breast cancer	3.17e-05	0.000326	CbGpPWpGaD
Baclofen—Decreased appetite—Doxorubicin—breast cancer	3.16e-05	0.000107	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IL2—breast cancer	3.16e-05	0.000326	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—breast cancer	3.15e-05	0.000324	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KDR—breast cancer	3.14e-05	0.000324	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Doxorubicin—breast cancer	3.14e-05	0.000107	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—breast cancer	3.14e-05	0.000107	CcSEcCtD
Baclofen—Urticaria—Epirubicin—breast cancer	3.13e-05	0.000106	CcSEcCtD
Baclofen—Pain—Doxorubicin—breast cancer	3.11e-05	0.000106	CcSEcCtD
Baclofen—Constipation—Doxorubicin—breast cancer	3.11e-05	0.000106	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—breast cancer	3.11e-05	0.000106	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—breast cancer	3.11e-05	0.000106	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCND1—breast cancer	3.08e-05	0.000318	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—breast cancer	3.08e-05	0.000317	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ESR1—breast cancer	3.06e-05	0.000316	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CTNNB1—breast cancer	3.05e-05	0.000314	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FN1—breast cancer	3.03e-05	0.000312	CbGpPWpGaD
Baclofen—Asthenia—Methotrexate—breast cancer	3.02e-05	0.000102	CcSEcCtD
Baclofen—Feeling abnormal—Doxorubicin—breast cancer	3e-05	0.000102	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MMP9—breast cancer	2.99e-05	0.000308	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NFKBIA—breast cancer	2.99e-05	0.000308	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—breast cancer	2.98e-05	0.000307	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Doxorubicin—breast cancer	2.98e-05	0.000101	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PTEN—breast cancer	2.97e-05	0.000306	CbGpPWpGaD
Baclofen—Pruritus—Methotrexate—breast cancer	2.97e-05	0.000101	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NOTCH1—breast cancer	2.96e-05	0.000305	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—breast cancer	2.95e-05	0.000303	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK8—breast cancer	2.91e-05	0.0003	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—AKT1—breast cancer	2.9e-05	0.000299	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—APC—breast cancer	2.89e-05	0.000298	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—breast cancer	2.89e-05	0.000298	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KIT—breast cancer	2.89e-05	0.000298	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—breast cancer	2.89e-05	9.82e-05	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—breast cancer	2.88e-05	9.78e-05	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—breast cancer	2.88e-05	9.78e-05	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—breast cancer	2.88e-05	9.77e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—EGF—breast cancer	2.86e-05	0.000295	CbGpPWpGaD
Baclofen—Asthenia—Epirubicin—breast cancer	2.82e-05	9.59e-05	CcSEcCtD
Baclofen—Pruritus—Epirubicin—breast cancer	2.78e-05	9.46e-05	CcSEcCtD
Baclofen—Dizziness—Methotrexate—breast cancer	2.78e-05	9.44e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—breast cancer	2.77e-05	0.000286	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SRC—breast cancer	2.76e-05	0.000284	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—BRAF—breast cancer	2.72e-05	0.00028	CbGpPWpGaD
Baclofen—Diarrhoea—Epirubicin—breast cancer	2.69e-05	9.14e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—VEGFA—breast cancer	2.69e-05	0.000277	CbGpPWpGaD
Baclofen—Vomiting—Methotrexate—breast cancer	2.67e-05	9.08e-05	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—RAF1—breast cancer	2.66e-05	0.000274	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT3—breast cancer	2.66e-05	0.000274	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IGF1—breast cancer	2.65e-05	0.000273	CbGpPWpGaD
Baclofen—Rash—Methotrexate—breast cancer	2.65e-05	9e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—AKT2—breast cancer	2.65e-05	0.000273	CbGpPWpGaD
Baclofen—Dermatitis—Methotrexate—breast cancer	2.65e-05	9e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—EGFR—breast cancer	2.64e-05	0.000272	CbGpPWpGaD
Baclofen—Headache—Methotrexate—breast cancer	2.63e-05	8.95e-05	CcSEcCtD
Baclofen—Asthenia—Doxorubicin—breast cancer	2.61e-05	8.87e-05	CcSEcCtD
Baclofen—Dizziness—Epirubicin—breast cancer	2.6e-05	8.84e-05	CcSEcCtD
Baclofen—Pruritus—Doxorubicin—breast cancer	2.58e-05	8.75e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—breast cancer	2.54e-05	0.000262	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—breast cancer	2.54e-05	0.000262	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—breast cancer	2.52e-05	0.00026	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—breast cancer	2.52e-05	0.000259	CbGpPWpGaD
Baclofen—Vomiting—Epirubicin—breast cancer	2.5e-05	8.5e-05	CcSEcCtD
Baclofen—Nausea—Methotrexate—breast cancer	2.5e-05	8.48e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—KRAS—breast cancer	2.49e-05	0.000257	CbGpPWpGaD
Baclofen—Diarrhoea—Doxorubicin—breast cancer	2.49e-05	8.46e-05	CcSEcCtD
Baclofen—Rash—Epirubicin—breast cancer	2.48e-05	8.43e-05	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—breast cancer	2.48e-05	8.42e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MYC—breast cancer	2.47e-05	0.000255	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—breast cancer	2.47e-05	0.000254	CbGpPWpGaD
Baclofen—Headache—Epirubicin—breast cancer	2.46e-05	8.37e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EGFR—breast cancer	2.42e-05	0.000249	CbGpPWpGaD
Baclofen—Dizziness—Doxorubicin—breast cancer	2.41e-05	8.18e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NOS3—breast cancer	2.4e-05	0.000248	CbGpPWpGaD
Baclofen—Nausea—Epirubicin—breast cancer	2.34e-05	7.94e-05	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—breast cancer	2.31e-05	7.86e-05	CcSEcCtD
Baclofen—Rash—Doxorubicin—breast cancer	2.29e-05	7.8e-05	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—breast cancer	2.29e-05	7.79e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—breast cancer	2.29e-05	0.000236	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—breast cancer	2.28e-05	0.000235	CbGpPWpGaD
Baclofen—Headache—Doxorubicin—breast cancer	2.28e-05	7.75e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MDM2—breast cancer	2.28e-05	0.000235	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAF1—breast cancer	2.27e-05	0.000234	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RELA—breast cancer	2.26e-05	0.000233	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB2—breast cancer	2.25e-05	0.000232	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—breast cancer	2.22e-05	0.000229	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—breast cancer	2.22e-05	0.000229	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—breast cancer	2.16e-05	7.35e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CXCL8—breast cancer	2.13e-05	0.00022	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HRAS—breast cancer	2.12e-05	0.000218	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—breast cancer	2.1e-05	0.000216	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—breast cancer	2.08e-05	0.000214	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—breast cancer	2.06e-05	0.000212	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CASP3—breast cancer	2.04e-05	0.00021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—breast cancer	2.04e-05	0.00021	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—breast cancer	2.03e-05	0.000209	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—breast cancer	2.03e-05	0.000209	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCND1—breast cancer	1.99e-05	0.000205	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JUN—breast cancer	1.98e-05	0.000204	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNB1—breast cancer	1.97e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HRAS—breast cancer	1.94e-05	0.0002	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—breast cancer	1.93e-05	0.000199	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—breast cancer	1.92e-05	0.000198	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—breast cancer	1.92e-05	0.000197	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK8—breast cancer	1.88e-05	0.000193	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—AKT1—breast cancer	1.87e-05	0.000193	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—breast cancer	1.86e-05	0.000191	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SRC—breast cancer	1.78e-05	0.000183	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—breast cancer	1.73e-05	0.000178	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—breast cancer	1.71e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—breast cancer	1.71e-05	0.000177	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK3—breast cancer	1.64e-05	0.000169	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MYC—breast cancer	1.59e-05	0.000164	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—breast cancer	1.59e-05	0.000164	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—breast cancer	1.56e-05	0.000161	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KRAS—breast cancer	1.47e-05	0.000152	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—breast cancer	1.35e-05	0.000139	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—breast cancer	1.31e-05	0.000135	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—breast cancer	1.25e-05	0.000129	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—breast cancer	1.2e-05	0.000123	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—breast cancer	1.1e-05	0.000114	CbGpPWpGaD
